Rapid Micro Biosystems makes the Growth Direct quality control system and consumables for pharmaceutical manufacturers. RPID reports earnings on Fri, Nov 6, 2026.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Sep 29 | Roth Capital | Initiated | Buy | |
| May 29 | Keybanc | Maintained | Buy | |
| May 22 | Lake Street | Maintained | Buy |
Seasonality
How RPID has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.
Whale Options Flow
90DNo whale options trades in RPID in the last 90 days.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether RPID is in one of them and how their past RPID trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered RPID in an article yet. Here's the latest on the wider market.
About Rapid Micro Biosystems
Rapid Micro Biosystems makes laboratory systems and consumables used for quality control testing in manufacturing. Its main product is the Growth Direct system, which it sells along with consumables. Its main customers are pharmaceutical manufacturers, mostly in North America and Europe, with some sales in Asia-Pacific. The company is based in Lexington, Massachusetts, and also sells through a distribution partner.
- Headquarters
- Lexington, MA